Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C9orf72 is a protein involved in several cellular processes including RNA metabolism, vesicle trafficking, autophagy, and immune modulation. A hexanucleotide repeat expansion within the C9orf72 gene is a major genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The expansion leads to both loss-of-function and gain-of-toxicity mechanisms, disrupting cellular homeostasis and contributing to neurodegeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 72 (C9orf72).